secwatch.observer — SEC 8-K summary
======================================

Issuer:     AbCellera Biologics Inc. (ABCL)
CIK:        0001703057
Form:       8-K
Filed at:   2025-11-12T23:59:59+00:00
Accession:  0001703057-25-000029
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AbCellera appoints Dr. Stephen Quake to board; Dr. Andrew Lo resigns
--------------------------------------------------------------------

- Dr. Stephen Quake (Stanford professor, Chan Zuckerberg Biohub founder) appointed independent director effective Nov 10, 2025.
- Quake joins Audit and Nominating and Corporate Governance committees; qualifies as independent under NASDAQ rules.
- Dr. Andrew Lo resigned effective Nov 10, 2025; resignation not due to any disagreement with company.
- Lo served on board since Dec 2021; was on Audit and Nominating and Corporate Governance committees.
- Quake will receive standard non-employee director compensation per company policy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1703057/000170305725000029/0001703057-25-000029-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1703057/000170305725000029/abcl-20251110.htm
  HTML page:      https://secwatch.observer/filing/0001703057-25-000029

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer